DWIGHT GENEROSO: Open Payments
NPI 1831812544 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 32 payments from 15 companies in 2025. Trend: 2023 $597 · 2024 $182 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $318 |
| Agios Pharmaceuticals, Inc. | 3 | $185 |
| Chiesi USA, Inc. | 5 | $91 |
| Novo Nordisk Inc | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| HEMA Biologics, LLC | 2 | $57 |
| Medexus Pharma, Inc. | 2 | $51 |
| BioMarin Pharmaceutical Inc. | 1 | $49 |
| PFIZER INC. | 1 | $38 |
| Octapharma USA, Inc. | 1 | $29 |
Products named: PYRUKYND, ALTUVIIIO, QFITLIA, Alhemo, Jivi, SEVENFACT, FERRIPROX, IXINITY.
Industry payments across NV — which companies pay providers there.
